Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Aquaporin 4 in Traumatic Brain Injury: From Molecular Pathways to Therapeutic Target Publisher Pubmed



Dadgostar E1, 2 ; Rahimi S3 ; Nikmanzar S4 ; Nazemi S5 ; Naderi Taheri M6 ; Alibolandi Z7 ; Aschner M8 ; Mirzaei H9 ; Tamtaji OR6
Authors

Source: Neurochemical Research Published:2022


Abstract

Traumatic brain injury (TBI) is known as an acute degenerative pathology of the central nervous system, and has been shown to increase brain aquaporin 4 (AQP4) expression. Various molecular mechanisms affect AQP4 expression, including neuronal high mobility group box 1, forkhead box O3a, vascular endothelial growth factor, hypoxia-inducible factor-1 α (HIF-1 α) sirtuin 2, NF-κB, Malat1, nerve growth factor and Angiotensin II receptor type 1. In addition, inhibition of AQP4 with FK-506, MK-801 (indirectly by targeting N-methyl-d-aspartate receptor), inactivation of adenosine A2A receptor, levetiracetam, adjudin, progesterone, estrogen, V1aR inhibitor, hypertonic saline, erythropoietin, poloxamer 188, brilliant blue G, HIF-1alpha inhibitor, normobaric oxygen therapy, astaxanthin, epigallocatechin-3-gallate, sesamin, thaliporphine, magnesium, prebiotic fiber, resveratrol and omega-3, as well as AQP4 gene silencing lead to reduced edema upon TBI. This review summarizes current knowledge and evidence on the relationship between AQP4 and TBI, and the potential mechanisms involved. © 2021, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Other Related Docs
11. Nmda Receptors Antagonists Alleviated the Acute Phase of Traumatic Brain Injury, Iranian Journal of Basic Medical Sciences (2025)
12. Therapeutic Effects of Anti-Diabetic Drugs on Traumatic Brain Injury, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2024)
14. Inflammasome: Its Role in Traumatic Brain and Spinal Cord Injury, Journal of Cellular Physiology (2018)